← Back to Clinical Trials
Recruiting NCT07765186

NCT07765186 Spatial Cues, Task Demands, and Auditory Selective Attention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07765186
Status Recruiting
Phase
Sponsor University of South Florida
Condition Bilateral Cochlear Implants
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-10-22
Primary Completion 2030-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Existing bilateral cochlear implantsNormal Hearing Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-10-22 with a primary completion date of 2030-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Understanding speech in restaurants and other noisy environments is the most common complaint from the more than 60 million Americans with hearing impairment. Succeeding in such environments requires a listener to first segregate sound sources and then selectively attend to the source of interest. This study examines how individual auditory spatial cues (interaural time differences and interaural level differences) support spatial selective attention, the cortical processes that underlie this ability, and how these processes are modulated by task demands. Participants with normal hearing and participants who use bilateral cochlear implants will perform listening tasks while brain and physiological responses are recorded (electroencephalography, functional near-infrared spectroscopy, pupillometry, and, for normal-hearing participants only, functional magnetic resonance imaging). The findings will provide new insights into the mechanisms of spatial selective attention and help guide clinical solutions for cochlear implant users, individuals with hearing impairment more generally, and older normal-hearing adults who have difficulty understanding speech in noisy environments.

Eligibility Criteria

Inclusion Criteria: * Adults with normal hearing, confirmed by audiometric assessment (thresholds within 20 dB HL of normal through 8 kHz), OR adults with bilateral cochlear implants who have used their implants for at least one year * Native speakers of American English * Normal or corrected-to-normal vision Exclusion Criteria: * Known neurological disorders * For fMRI sessions (normal-hearing participants only): contraindications to MRI scanning; cochlear implant users do not complete MRI sessions

Contact & Investigator

Central Contact

Christopher A Brown, PhD

✉ cb43@usf.edu

📞 412-670-2772

Principal Investigator

Christopher A Brown, PhD

PRINCIPAL INVESTIGATOR

University of South Florida

Frequently Asked Questions

Who can join the NCT07765186 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Bilateral Cochlear Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07765186 currently recruiting?

Yes, NCT07765186 is actively recruiting participants. Contact the research team at cb43@usf.edu for enrollment information.

Where is the NCT07765186 trial being conducted?

This trial is being conducted at Tampa, United States.

Who is sponsoring the NCT07765186 clinical trial?

NCT07765186 is sponsored by University of South Florida. The principal investigator is Christopher A Brown, PhD at University of South Florida. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology